Sickle cell disease (SCD) is the most common genetic hemoglobin disorder in which there is an inheritance of mutant hemoglobin genes from both parents. Iron status in patients with sickle cell anaemia is a matter of continuing investigation. In this study, children with sickle cell anemia were evaluated for iron deficiency. Iron deficiency anaemia being symptomatic is easily recognizable and treated but there are no specific symptoms related to iron overload unless and until the patient reaches to a level of iron toxicity which then becomes too late for chelation therapy and the hepatotoxicity and cardiotoxicity secondary to iron overload may then become irreversible. We are well aware of chelation therapy in thalassemics but no such protocol has ever been laid down for patients of sickle cell anaemiaddd
